PASSAGE BIO, INC.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $-45.5M | $-64.8M | $-102.1M | $-136.1M | $-185.4M | $-112.2M | $-45.6M |
| Depreciation & Amortization | $728.0K | $3.1M | $3.7M | $3.7M | $1.5M | $800.0K | $134.0K |
| Depreciation | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — |
| Stock-Based Compensation | $3.0M | $5.8M | $10.9M | $19.0M | $32.7M | $14.6M | $1.5M |
| Net Cash from Operating Activities | $-31.5M | $-48.0M | $-78.3M | $-118.2M | $-126.9M | $-80.5M | $-39.9M |
| Investing Activities | |||||||
| Capital Expenditures | — | $34.0K | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $40.2M | $54.9M | $65.2M | $25.2M | $-45.8M | $-172.1M | $-1.7M |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $23.0K | $8.9M | $135.0K | $-1.4M | $166.7M | $228.8M | $175.6M |
| Net Change in Cash | $8.7M | $15.9M | $-12.9M | $-94.4M | $-6.0M | $-23.9M | $134.0M |
| Free Cash Flow | — | $-48.0M | — | — | — | — | — |